Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
214.31 USD | -0.91% | +1.57% | +4.60% |
Dec. 05 | Iqvia Holdings Insider Sold Shares Worth $2,807,472, According to a Recent SEC Filing | MT |
Dec. 04 | Let's party like it's 2021 | ![]() |
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Calendar
2024-02-13
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
BUY
Number of Analysts
21
Last Close Price
214.31USD
Average target price
230.52USD
Spread / Average Target
+7.56%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.60% | 39 469 M $ | |
+67.95% | 40 210 M $ | |
-56.42% | 30 453 M $ | |
-26.33% | 28 080 M $ | |
+38.74% | 21 949 M $ | |
-28.31% | 21 694 M $ | |
+1.31% | 17 245 M $ | |
-13.59% | 11 276 M $ | |
-22.32% | 10 327 M $ | |
-8.98% | 10 291 M $ |
- Stock
- Equities
- Stock Iqvia Holdings Inc. - Nyse
- News Iqvia Holdings Inc.
- IQVIA Holdings Q2 Adjusted Earnings Decline, Revenue Rises; Company Cuts 2023 Outlook, Increases Share Buyback Program